|
시장보고서
상품코드
1736702
정형외과용 임플란트 시장 규모 : 임플란트 유형별, 용도별, 최종 사용자별, 지역범위별 및 예측Global Orthopedic Implants Market Size By Kind Of Implant, By Application, By Final User (Hospitals, Ambulatory Surgical Centers Orthopedic Clinics), By Geographic Scope And Forecast |
||||||
정형외과용 임플란트 시장 규모는 2024년에 495억 1,000만 달러로 평가되었고, 2026-2032년 CAGR 4.90%로 성장할 전망이며, 2032년에는 700억 9,000만 달러에 이를 것으로 예측되고 있습니다.
정형외과용 임플란트는 골절된 뼈와 관절을 수리하거나 지지하는 의료기기입니다. 나사, 플레이트, 로드, 인공 관절은 치유 과정을 돕고 기능을 회복시키는 데 사용됩니다. 정형외과용 임플란트는 일반적으로 관절 치환, 골절 교정, 척추 안정화 등의 수술에 사용됩니다.
그 용도는 외상, 퇴행성 질환, 선천성 문제 등 폭넓은 질환에 이르고 있으며, 다양한 환자 집단에 대한 치료의 성공을 보장하고 있습니다. 재료 과학 및 바이오 테크놀로지의 진보는 정형외과용 임플란트에 희망찬 미래를 가리키고 있습니다.
3D 프린팅 임플란트 및 생리적 변화에 적응하는 스마트 재료와 같은 혁신적인 치료로 치료 성적이 향상되고, 보다 개인화된 의료 및 더 나은 환자 관리에 대한 길이 열릴 것으로 기대됩니다.
세계의 정형외과용 임플란트 시장을 형성하는 주요 시장 역학은 다음과 같습니다.
주요 시장 성장 촉진요인
변형성 관절증 및 근골격계 장애의 유병률 증가 : 변형성 관절증 및 기타 근골격계 질환의 빈도는 세계적으로 증가하고 있으며, 그 주요 원인은 인구의 고령화 및 비만률의 상승입니다. 이러한 경향은 정형외과 수술, 특히 고관절이나 슬관절 수술 등의 인공관절 치환술의 수요를 높입니다. 헬스케어 시스템이 이러한 요구에 부응하는 가운데 정형외과용 임플란트 제조업체는 환자의 전귀를 개선하기 위한 창조적인 솔루션을 우선시하고 있습니다. 예를 들어 2023년 3월 세계보건기구(WHO)는 관절 관련 질환의 급증을 보고하고 정형외과 헬스케어에 대한 추가 지출을 촉구했습니다.
임플란트의 설계 및 재료에 있어서 기술의 진보 : 저침습 수술 기술이나 선진 생체 재료의 개발 등, 정형외과용 임플란트 기술의 혁신이 시장 성장을 크게 견인하고 있습니다. 최근의 발전으로 보다 뛰어난 생체적합성, 회복시간의 단축, 전체적인 성능의 향상을 실현한 임플란트가 등장하고 있습니다. 2023년 1월, Stryker Corporation은 보다 높은 강도와 내구성을 제공하는 강화된 재료로 설계된 정형외과용 임플란트 신 시리즈를 출시하여 시장이 기술 진보에 주력하고 있음을 보여주었습니다.
정부의 이니셔티브 및 투자 : 의료 인프라를 개선하기 위한 최근의 정부 이니셔티브는 정형외과 임플란트 사업을 추진하고 있습니다. 예를 들어 미국 보건 복지부는 2023년 6월 정형외과 기술 연구를 지원하고 수술 혁신을 홍보하는 500만 달러의 프로젝트를 발표했습니다. 이 자금 지원은 기술 혁신을 촉진하고 치료 선택지를 개선하는 것을 목적으로 하고 있으며 정형외과 부문에 대한 투자를 더 많은 기업에 촉구하고 있습니다.
스포츠 의료 필요성 증가 : 스포츠 및 피트니스에 참여하는 사람들이 증가함에 따라 스포츠 관련 부상 수가 증가하고 정형외과용 임플란트에 대한 수요가 증가하고 있습니다. 각 기업은, 스포츠 상해의 치료에 특화한 임플란트나 기구를 개발하는 것으로 대응해, 이 부문의 시장 성장을 뒷받침하고 있습니다. 스미스 앤드 네퓨는, 2023년 8월에 스포츠 의료 제품 포트폴리오의 확충을 발표해, 이 급성장 부문에 대한 대처 자세를 나타냈습니다.
주요 이슈
임플란트 및 수술의 고가 비용 : 정형외과용 임플란트 및 외과 치료는 고액이 될 수 있으며, 특히 빈곤국가의 환자의 접근이 제한됩니다. 이 경제적 장벽은 헬스케어 시스템이나 환자가 대체 의료를 요구하거나 중요한 치료를 완전히 보류할 가능성이 있기 때문에 시장 확대에 방해가 될 수 있습니다.
엄격한 규제 요건 : 정형외과용 임플란트 시장은 환자의 안전성과 제품의 유효성을 보장하기 위해 엄격한 규제를 받고 있습니다. 이러한 엄격한 기준을 충족하는 것은 기업에 시간과 비용이 많이 들기 때문에 제품 출시가 지연되거나 개발비가 급등하여 수익성에 영향을 미칠 수 있습니다.
대체치료와의 경쟁 : 정형외과용 임플란트 산업은 물리치료, 약제요법, 생물학적 요법 등의 비침습적 치료와의 경쟁에 직면하고 있습니다. 통증 관리나 이동에 관한 우려에 대해 환자가 보다 저침습성 선택지를 요구하게 되면, 외과적 임플란트에 대한 수요가 감소하고, 제조사는 전략을 조정할 수밖에 없을 가능성이 있습니다.
합병증 및 임플란트 실패 : 환자는 감염, 임플란트 결함, 나쁜 반응 등의 위험을 이유로 정형외과 수술을 피할 수 있습니다. 이러한 위험은 임플란트 설계 및 재료의 지속적인 발전을 필요로 하기 때문에 제조사의 개발 부담이 증가하는 한편, 환자의 정형외과 치료에 대한 신뢰와 채용에도 영향을 미칩니다.
주요 동향
임플란트 및 수술의 고가의 비용 : 정형외과용 임플란트와 외과 치료는 고액이 될 수 있으며, 특히 가난한 국가에서는 환자의 접근이 제한됩니다. 이러한 경제적 장벽은 헬스케어 시스템이나 환자가 대체 의료를 찾거나 중요한 치료를 완전히 미룰 수 있기 때문에 시장 확대를 방해할 수 있습니다.
엄격한 규제 요건 : 정형외과용 임플란트 시장은 환자의 안전성과 제품의 유효성을 보장하기 위해 엄격한 규제를 받고 있습니다. 이러한 엄격한 기준을 충족하는 것은 기업에 시간과 비용이 많이 들기 때문에 제품 출시가 지연되거나 개발비가 급등하여 수익성에 영향을 미칠 수 있습니다.
대체치료와의 경쟁 : 정형외과용 임플란트 산업은 물리치료, 약제요법, 생물학적 요법 등의 비침습적 치료와의 경쟁에 직면하고 있습니다. 통증 관리나 이동에 관한 우려에 대해 환자가 보다 침습성이 낮은 선택지를 요구하게 되면 외과적 임플란트에 대한 수요가 감소할 가능성이 있어 제조사는 전략을 조정할 수밖에 없습니다.
합병증 및 임플란트 실패 : 환자는 감염, 임플란트 결함, 나쁜 반응 등의 위험을 이유로 정형외과 수술을 피할 수 있습니다. 이러한 위험은 임플란트의 설계나 재료에 대한 지속적인 진보를 필요로 하기 때문에 제조사의 개발 부담은 증대되고, 동시에 환자의 정형외과 치료에 대한 신뢰나 채용에도 영향을 미칩니다.
Orthopedic Implants Market size was valued at USD 49.51 Billion in 2024 and is projected to reach USD 70.09 Billion by 2032, growing at a CAGR of 4.90% from 2026 to 2032.
Orthopedic implants are medical devices that repair or support broken bones and joints. Screws, plates, rods, and prosthetic joints are used to aid in the healing process and restore function. Orthopedic implants are commonly used in surgeries to replace joints, correct fractures, and stabilize the spine.
Their applications cover a wide range of ailments, including trauma, degenerative diseases, and congenital problems, ensuring successful therapy for a diverse patient population. Advancements in materials science and biotechnology point to a hopeful future for orthopedic implants.
Innovations like 3D-printed implants and smart materials that adapt to physiological changes are expected to improve treatment outcomes, paving the path for more personalized medicine and better patient care.
The key market dynamics that are shaping the global orthopedic implants market include:
Key Market Drivers:
Increasing Prevalence of Osteoarthritis and Musculoskeletal Disorders: The frequency of osteoarthritis and other musculoskeletal problems is increasing worldwide, owing mostly to an ageing population and rising obesity rates. This tendency drives up demand for orthopedic procedures, notably joint replacements such as hip and knee surgery. As healthcare systems respond to this need, orthopedic implant makers prioritize creative solutions to improve patient outcomes. For example, in March 2023, the World Health Organization reported a surge in joint-related disorders, driving additional expenditure in orthopedic healthcare.
Technological Advancements in Implant Design and Materials: Innovations in orthopedic implant technology, including the development of minimally invasive surgical techniques and advanced biomaterials, are significantly driving market growth. Recent advancements have led to implants that offer better biocompatibility, reduced recovery times, and improved overall performance. In January 2023, Stryker Corporation launched a new range of orthopedic implants designed with enhanced materials that provide greater strength and durability, showcasing the market's focus on technological progress.
Governmental Initiatives and Investments: Recent government initiatives to improve healthcare infrastructure have boosted the orthopedic implants business. For example, in June 2023, the United States Department of Health and Human Services announced a $5 million project to support orthopedic technology research, thereby fostering innovation. This funding aims to foster innovation and improve treatment options, encouraging more companies to invest in the orthopedic sector.
Rising Need For Sports Medicine: As more people participate in sports and fitness activities, the number of sports-related injuries rises, driving up demand for orthopedic implants. Companies are reacting by creating specific implants and gadgets for treating sports injuries, hence boosting market growth in this area. Smith & Nephew announced the expansion of its sports medicine product portfolio in August 2023, demonstrating its commitment to serving this burgeoning sector.
Key Challenges:
High Costs of Implants and Procedures: Orthopedic implants and surgical treatments can be costly, limiting access for patients, especially in poor nations. This financial barrier might stymie market expansion, as healthcare systems and patients may seek alternatives or forego critical treatments entirely.
Strict Regulatory Requirements: The orthopedic implants market is closely regulated to ensure patient safety and product efficacy. Meeting these strict criteria can be time-consuming and expensive for businesses, potentially delaying product releases and raising development expenses, affecting profitability.
Competition from Alternative Treatments: The orthopedic implants industry faces competition from non-invasive treatments like physiotherapy, medicine, and biologic therapies. As patients seek less intrusive options for pain management and mobility concerns, demand for surgical implants may decline, forcing manufacturers to adjust their strategy.
Complications and Implant Failures: Patients may avoid orthopedic operations due to risks such as infections, implant failures, and bad reactions. These hazards need ongoing advancements in implant design and materials, which increases the development load for manufacturers while also influencing patient trust and adoption of orthopedic treatments.
Key Trends:
High Costs of Implants and Procedures: Orthopedic implants and surgical treatments can be costly, limiting access for patients, especially in poor nations. This financial barrier might stymie market expansion, as healthcare systems and patients may seek alternatives or forego critical treatments entirely.
Strict Regulatory Requirements: The orthopedic implants market is closely regulated to ensure patient safety and product efficacy. Meeting these strict criteria can be time-consuming and expensive for businesses, potentially delaying product releases and raising development expenses, affecting profitability.
Competition from Alternative Treatments: The orthopedic implants industry faces competition from non-invasive treatments like physiotherapy, medicine, and biologic therapies. As patients seek less intrusive options for pain management and mobility concerns, demand for surgical implants may decline, forcing manufacturers to adjust their strategy.
Complications and Implant Failures: Patients may avoid orthopedic operations due to risks such as infections, implant failures, and bad reactions. These hazards need ongoing advancements in implant design and materials, which increases the development load for manufacturers while also influencing patient trust and adoption of orthopedic treatments.
Here is a more detailed regional analysis of the global orthopedic implants market:
North America:
North America dominates the orthopedic implants market, owing to improved healthcare infrastructure, large healthcare expenditures, and an aging population. The region's well-established medical device industry, combined with large investments in R&D, allows for the speedy introduction of breakthrough devices. Furthermore, the frequency of musculoskeletal problems, particularly among the elderly, drives up demand for orthopedic treatments such joint replacements. Medtronic announced a $50 million investment in August 2023 to enhance its orthopedic product offerings, demonstrating its commitment to meeting the demands of this increasing patient population.
Furthermore, supportive government initiatives and regulatory frameworks improve the market environment in North America. The United States Food and Drug Administration (FDA) has shortened approval processes for orthopedic implants, allowing new technologies to enter the market more quickly. In July 2023, the FDA announced a new initiative to expedite the clearance of innovative orthopedic devices, which is projected to drive further growth in this industry. As a result, the combination of technological breakthroughs, strong healthcare systems, and supportive regulatory frameworks places North America as a market leader for orthopedic implants.
Asia Pacific:
The Asia Pacific area is emerging as the fastest-growing market for orthopedic implants, owing to rising industrialization, urbanization, and increased healthcare investments. The burgeoning middle-class population in nations such as China and India is driving up disposable incomes, increasing demand for modern healthcare services such as orthopedic procedures. Furthermore, the rising frequency of osteoarthritis and sports-related injuries is increasing the demand for orthopedic implants. In May 2023, the Indian government proposed a $3 billion investment in healthcare infrastructure, which is likely to increase access to orthopedic care and, as a result, demand for implants.
Furthermore, the Asia Pacific market is seeing substantial improvements in manufacturing technologies, including as 3D printing and novel materials, which are increasing the availability and customisation of orthopedic implants. Companies are increasingly turning to local manufacturing to cut costs and increase supply chain efficiency. Stryker Corporation, for example, will open a new factory in Singapore in September 2023 to manufacture sophisticated orthopedic implants specifically for the regional market. This relocation underscores not only rising demand, but also the strategic importance of the Asia Pacific area in the worldwide orthopedic implants landscape.
The Global Orthopedic Implants Market is segmented on the basis of By Kind Of Implants, By Application, By Final User and By Geography.
Based on Kind Of Implants, the Global Orthopedic Implants Market is segmented into Short Joint Replacements, Spinal Implants. The short joint replacements segment is the dominant category in the global orthopedic implants market, primarily due to the high prevalence of conditions like osteoarthritis and the increasing number of joint replacement surgeries. This segment benefits from advancements in implant technology and materials, leading to improved patient outcomes and higher adoption rates among healthcare providers. The spinal implants segment is the fastest growing segment in the orthopedic implants market, driven by the rising incidence of spinal disorders and an aging population.
Based on Application, the Global Orthopedic Implants Market is segmented into Hip Implants, Knee Implants, Spine implants, Shoulder Implants. The knee implants segment is the dominant category in the global orthopedic implants market, largely due to the high incidence of knee-related conditions such as osteoarthritis. The increasing number of knee replacement surgeries, supported by advancements in implant technology and materials, drives substantial market demand. The spine implants segment is the fastest growing segment in the orthopedic implants market, fueled by the rising prevalence of spinal disorders and injuries. Innovations in spinal surgery techniques and the development of advanced spinal devices are enhancing treatment options and driving rapid growth in this area.
Based on Final User, the Global Orthopedic Implants Market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Orthopedic Clinics. The hospitals segment is the dominant category in the global orthopedic implants market, primarily due to the high volume of surgical procedures performed in these facilities. The ambulatory surgical centers (ASCs) segment is the fastest growing segment in the orthopedic implants market, driven by the increasing preference for outpatient procedures. ASCs offer cost-effective solutions, shorter recovery times, and improved patient convenience, leading to a rise in orthopedic surgeries performed in these settings.
Based on the Geography, the Global Orthopedic Implants Market are classified into North America, Europe, Asia Pacific, Rest of the World. North America is the dominant region, owing to its advanced industrial infrastructure and widespread use of precision measurement technologies across industries. The Asia Pacific region is the fastest growing, thanks to rapid industrialization, expanding manufacturing capabilities, and rising investments in technology and infrastructure in emerging economies such as China and India.
The "Global Orthopedic Implants Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Johnson & Johnson Services Inc., Zimmer Biomet, Stryker Corporation, Medtronic plc, Smith & Nephew plc, Exactech, Inc. and B. Braun Melsungen AG.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.